<?xml version="1.0" encoding="ISO-8859-1" ?>
	<rss version="0.91">
	  <channel>
	  <copyright>Copyright 2008 Medical News Today</copyright>
	  <description>Latest Erectile Dysfunction / Premature Ejaculation News From Medical News Today.</description>
	  <link>http://www.medicalnewstoday.com/sections/erectile_dysfunction/</link>
	  <title>Erectile Dysfunction / Premature Ejaculation News From Medical News Today</title>
	  <webMaster>admin&#064;medicalnewstoday.com  (MNT Admin)</webMaster>
	  <managingEditor>editors&#064;medicalnewstoday.com  (MNT Editors)</managingEditor>
	  <language>en-us</language><item><title>Peyronie's Disease: Characteristics &#38; Treatments</title><pubDate>Tue, 08 Jul 2008 00:00:00 PDT</pubDate><link>http://www.medicalnewstoday.com/articles/114135.php</link><description>Peyronie's disease is characterized by a plaque, or hard lump, that develops on the upper or lower side of the penis in layers containing erectile tissue. It starts with an inflammation and can develop into a hardened scar. Symptoms may develop slowly or appear overnight and they consist of reduced flexibility, pain, curved and shortened penis during erection. The curvature of the penis generally leads to lowered self&#45;esteem and makes sexual intercourse difficult, almost impossible.</description></item><item><title>Erectile Dysfunction Lower In Men Who Have Intercourse More Often</title><pubDate>Wed, 02 Jul 2008 04:00:00 PDT</pubDate><link>http://www.medicalnewstoday.com/articles/113613.php</link><description>Having intercourse more often may help prevent the development of erectile dysfunction (ED). A study published in the July 2008 issue of The American Journal of Medicine reports that researchers have found that men who had intercourse more often were less likely to develop ED.</description></item><item><title>Erectile Dysfunction After Plaque Incision And Grafting: Incidence And Predictors</title><pubDate>Wed, 02 Jul 2008 03:00:00 PDT</pubDate><link>http://www.medicalnewstoday.com/articles/113559.php</link><description>ORLANDO, FL (UroToday.com) &#45; In this presentation, the group reported on the incidence and predictors of erectile dysfunction after plaque incision and grafting (PIG).     56 patients undergoing PIG were analyzed with pre and 6&#45;month postoperative IIEF questionnaires. Mean duration of PD at the time of surgery was 23 months, mean plaque area was 4.7 cm2 and mean pre&#45;op curvature was 52 degrees. 52 patients had grafting with Tutoplast, 4 with Surgisis.</description></item><item><title>Viagra&#45;Like Effects From Watermelon</title><pubDate>Tue, 01 Jul 2008 03:00:00 PDT</pubDate><link>http://www.medicalnewstoday.com/articles/113422.php</link><description>A cold slice of watermelon has long been a Fourth of July holiday staple. But according to recent studies, the juicy fruit may be better suited for Valentine's Day.    That's because scientists say watermelon has ingredients that deliver Viagra&#45;like effects to the body's blood vessels and may even increase libido.    "The more we study watermelons, the more we realize just how amazing a fruit it is in providing natural enhancers to the human body," said Dr.</description></item><item><title>Complications Of Penile Prosthesis Surgery</title><pubDate>Thu, 26 Jun 2008 04:00:00 PDT</pubDate><link>http://www.medicalnewstoday.com/articles/112797.php</link><description>ORLANDO, FL (UroToday.com) &#45; Dr. Levine moderated this session on penile prosthetic (PP) surgery. Penile prosthetic devices have been implanted for over 40 years.     The overall satisfaction with penile implants in one study was 83%, compared to 51% for PDE5 inhibitors and about 30% for injection therapy. About a 10% mechanical failure rate can be expected at 10 years, although it may decrease with newer devices.</description></item><item><title>Adult Stem Cell Therapy For Erectile Dysfunction</title><pubDate>Thu, 26 Jun 2008 00:00:00 PDT</pubDate><link>http://www.medicalnewstoday.com/articles/112789.php</link><description>ORLANDO, FL (UroToday.com) &#45; Dr. Tom Lue discussed autologous stem cell use for ED. He discussed that ability for the planarian species to regenerate any part of its body, but the salamander can only regenerate a limb. In man there are also stem cells, which are undifferentiated cells that have potential to also regenerate.     In adipose tissue there are stem cells as demonstrated by immunohistochemistry, RT&#45;PCR and Western blotting experiments.</description></item><item><title>40Over40: A New Campaign To Tackle Low Awareness Of Erectile Dysfunction And Its Health Implications In Younger Men</title><pubDate>Tue, 24 Jun 2008 00:00:00 PDT</pubDate><link>http://www.medicalnewstoday.com/articles/112427.php</link><description>A new survey of 1,000 men aged over 40, commissioned by Eli Lilly and Company Limited (Lilly UK) as part of a new erectile dysfunction awareness campaign, 40over40, reveals that just over 10% of men in their early 40s are aware that ED strikes regularly in the fourth decade even though evidence suggests that 40% of men aged 40 or over have some form of ED.</description></item><item><title>1 In 10 Men Suffer From Erectile Dysfunction Due To Work Related Stress</title><pubDate>Fri, 20 Jun 2008 01:00:00 PDT</pubDate><link>http://www.medicalnewstoday.com/articles/112046.php</link><description>New research has shown that 1 in 10 men experience erectile dysfunction   (ED) and as many as 1 in 5 men suffer a loss of libido, as a result of   work&#45;related stress.     These latest figures suggest that 90% of men have shown at least one   clinical feature of stress due to work but only 54% of men know that   stress from work may be the cause of their ED. Stress, either at work or   home, is a known cause of ED and prolonged stress is associated with low   testosterone levels.</description></item><item><title>Men Treated For Prostate Cancer Experience High Levels Of Psychological Distress After Treatment</title><pubDate>Tue, 17 Jun 2008 00:00:00 PDT</pubDate><link>http://www.medicalnewstoday.com/articles/111455.php</link><description>Men treated for prostate cancer have high levels of psychological distress and many suffer ongoing sexual dysfunction and lower urinary tract symptoms, according to a survey of men in England designed to explore their supportive care needs.   Prostate cancer is the commonest solid cancer in men, accounting for one in every four cancers diagnosed in males in England in 2004.</description></item><item><title>Low Testosterone May Cause Health Problems That Lead To Erectile Dysfunction</title><pubDate>Mon, 16 Jun 2008 01:00:00 PDT</pubDate><link>http://www.medicalnewstoday.com/articles/111391.php</link><description>Men with erectile dysfunction should be examined for testosterone deficiency and the metabolic syndrome, because these conditions commonly occur together, a new study shows. The results will be presented at The Endocrine Society's 90th Annual Meeting in San Francisco.    "Erectile dysfunction is a portal into men's health," said the study's senior author, Aksam Yassin, MD, PhD, of the Clinic for Urology and Andrology of the Segeberger Clinics in Norderstedt, Germany.</description></item><item><title>Phosphodiesterase Type 5 Inhibitors In Management Of Erectile Dysfunction Secondary To Treatments For Prostate Cancer</title><pubDate>Thu, 12 Jun 2008 11:00:00 PDT</pubDate><link>http://www.medicalnewstoday.com/articles/111058.php</link><description>UroToday.com &#45; A group from the UK led by Bridget Candy report a meta&#45;analysis in the BJU International on phosphodiesterase type 5 inhibitors (PDE5i) for the treatment of erectile dysfunction (ED) secondary to treatments for prostate cancer (CaP).     Only randomized controlled trials were included and outcomes using validated scales such as the IIEF and SEP, successful sexual intercourse, time to effect, treatment satisfaction and health&#45;related QOL were extracted.</description></item><item><title>Rexahn Pharmaceuticals Initiates Phase II Trial For ZoraxelTM To Treat Erectile Dysfunction</title><pubDate>Thu, 05 Jun 2008 01:00:00 PDT</pubDate><link>http://www.medicalnewstoday.com/articles/109923.php</link><description>Rexahn Pharmaceuticals, Inc. (AMEX:RNN), a biopharmaceutical company dedicated to the discovery, development, and commercialization of innovative treatments for cancer, central nervous system disorders, sexual dysfunction and other unmet medical needs, announced that the Company has initiated a Phase II clinical trial for its lead clinical compound ZoraxelTM, for the treatment of Erectile Dysfunction (ED). ZoraxelTM is being developed as an orally administered, on&#45;demand&#45;use tablet.</description></item><item><title>FDA Requests Recall Of Xiadafil VIP Tabs</title><pubDate>Sat, 31 May 2008 00:00:00 PDT</pubDate><link>http://www.medicalnewstoday.com/articles/109390.php</link><description>The U.S. Food and Drug Administration requested that SEI Pharmaceuticals, of Miami, Fla., recall all Xiadafil VIP Tabs sold in 8 tablet bottles (Lot # 6K029) or blister cards of 2 tablets (Lot # 6K029&#45;SEI) because these products contain a potentially harmful, undeclared ingredient that may dangerously affect a person's blood pressure and can cause other life&#45;threatening side effects. These lots of Xiadafil VIP Tabs bear an expiration date of September 2009 (09/09).</description></item><item><title>FDA Requests Recall Of Xiadafil VIP Tabs</title><pubDate>Wed, 28 May 2008 03:00:00 PDT</pubDate><link>http://www.medicalnewstoday.com/articles/108948.php</link><description>The U.S. Food and Drug Administration requested that SEI Pharmaceuticals, of Miami, Fla., recall all Xiadafil VIP Tabs sold in 8 tablet bottles (Lot # 6K029) or blister cards of 2 tablets (Lot # 6K029&#45;SEI) because these products contain a potentially harmful, undeclared ingredient that may dangerously affect a person's blood pressure and can cause other life&#45;threatening side effects. These lots of Xiadafil VIP Tabs bear an expiration date of September 2009 (09/09).</description></item><item><title>Erectile Dysfunction And Diabetes</title><pubDate>Fri, 23 May 2008 01:00:00 PDT</pubDate><link>http://www.medicalnewstoday.com/articles/108498.php</link><description> "Men with diabetes who are having trouble keeping an erection could be at increased risk of serious heart problems", BBC News reported. It said that a study has found that those with erectile dysfunction are twice as likely as other men with diabetes to develop heart disease. This finding could apparently be used to "alert both patients and healthcare providers to the future risk of coronary heart disease".</description></item><item><title>Premature Ejaculation: International Consensus Will Aid Future Diagnosis, Treatment And Research</title><pubDate>Fri, 23 May 2008 00:00:00 PDT</pubDate><link>http://www.medicalnewstoday.com/articles/108470.php</link><description>International experts from ten countries have teamed up to develop the first ever evidence&#45;based definition of lifelong premature ejaculation (PE) in the hope that it will aid future diagnosis, treatment and research.</description></item><item><title>Erectile Dysfunction Not Only Interferes With Romance, It Warns Of Future Heart Disease</title><pubDate>Tue, 20 May 2008 05:00:00 PDT</pubDate><link>http://www.medicalnewstoday.com/articles/108107.php</link><description>Erectile dysfunction is always a matter of the heart, but new research shows that more than romance is at stake. Two new studies of men with type 2 diabetes found that erectile dysfunction (ED) was a powerful early warning sign for serious heart disease, including heart attack and death.</description></item><item><title>Maxi&#45;K Gene Transfer May Prove To Be Safe And Effective Erectile Dysfunction Treatment</title><pubDate>Sun, 18 May 2008 00:00:00 PDT</pubDate><link>http://www.medicalnewstoday.com/articles/107763.php</link><description>Maxi&#45;K gene therapy may be a safe and effective future option for men whose erectile dysfunction (ED) is not treatable with oral therapy. Two studies presented at the 103rd Annual Scientific Meeting of the American Urological Association (AUA) may give hope to these individuals. Researchers present their findings to reporters in a special press conference on May 20, 2008 at 10 a.m.</description></item><item><title>Maxi&#45;K Gene Transfer May Prove To Be Safe And Effective Erectile Dysfunction Treatment</title><pubDate>Thu, 15 May 2008 05:00:00 PDT</pubDate><link>http://www.medicalnewstoday.com/articles/107509.php</link><description>Maxi&#45;K gene therapy may be a safe and effective future option for men whose erectile dysfunction (ED) is not treatable with oral therapy. Two studies presented at the 103rd Annual Scientific Meeting of the American Urological Association (AUA) may give hope to these individuals. Researchers will present their findings to reporters in a special press conference on May 20, 2008 at 10 a.m.</description></item><item><title>Definition Of Premature Ejaculation By International Society For Sexual Medicine (ISSM)</title><pubDate>Thu, 15 May 2008 05:00:00 PDT</pubDate><link>http://www.medicalnewstoday.com/articles/107506.php</link><description>Despite the fact that it has long been a major concern for men, an evidence&#45;based definition for premature ejaculation has not existed until now. In October 2007, the International Society for Sexual Medicine (ISSM) gathered the world's leading sexual health experts to develop an evidence&#45;based definition of premature ejaculation. Experts will present the definition to reporters in a special press conference on May 19th at Monday, May 19, 2008 at 10:00 a.m.</description></item><item><title>Erectile Dysfunction After External Beam Radiotherapy For Prostate Cancer</title><pubDate>Sat, 10 May 2008 00:00:00 PDT</pubDate><link>http://www.medicalnewstoday.com/articles/106854.php</link><description>UroToday.com &#45; Currently, the most common curative treatment options for men with localized prostate cancer are radical prostatectomy, external beam radiotherapy and interstitial permanent brachytherapy and radical prostatectomy. Treatment decisions should particularly consider the specific risk and toxicity profile of a treatment method.</description></item><item><title>New Penile Pump Could Improve Patient Satisfaction, Confidence</title><pubDate>Fri, 02 May 2008 01:00:00 PDT</pubDate><link>http://www.medicalnewstoday.com/articles/106011.php</link><description>Erectile dysfunction (ED) has a dramatic impact on quality of life. Treatments for ED continue to improve, and penile prostheses have one of the highest patient satisfaction rates. In the April 2008 issue of Urologic Nursing, Susanne A. Quallich, Dana A. Ohl and Rodney L. Dunn survey urologic health care practitioners to find the penile prosthesis pump that is easiest to use and teach to patients.</description></item><item><title>Teaching Patients To Use Their Penile Prosthesis Requires Compassion</title><pubDate>Fri, 02 May 2008 01:00:00 PDT</pubDate><link>http://www.medicalnewstoday.com/articles/106009.php</link><description>While penile prosthesis devices are the most invasive and least chosen treatments for erectile dysfunction (ED), the devices garner the highest patient satisfaction rates. In the April 2008 issue of Urologic Nursing, Annette Liechty and Susanne A. Quallich review a teaching process that nurses can use to show a patient to successfully operate the device.</description></item><item><title>Fewer Complications From Minimally Invasive Pancreas Surgery</title><pubDate>Mon, 28 Apr 2008 02:00:00 PDT</pubDate><link>http://www.medicalnewstoday.com/articles/105504.php</link><description>When surgeons need to remove part of the pancreas, performing the operation with minimally invasive techniques offers patients a shorter hospital stay and fewer complications, researchers have concluded.    A study of more than 660 operations to remove pancreatic tumors and cysts over five years found that after laparoscopic surgery, patients stayed a third less time in the hospital without experiencing more complications such as leaks.</description></item><item><title>Correlation Between Erectile Dysfunction And LUTS The AUA Lecture</title><pubDate>Sat, 19 Apr 2008 00:00:00 PDT</pubDate><link>http://www.medicalnewstoday.com/articles/104486.php</link><description>UroToday.com &#45; Dr. Kevin McVary (Chicago) presented the AUA lecture. The incidence of ED increases to over 60% by age 60. He showed data that ED increases with increasing severity of LUTS, independent of age. Across all age groups, increasing LUTS correlated with worse ED even after adjusting for other factors such as diabetes mellitus. This suggests a common pathophysiology or causal relationship between ED and LUTS.</description></item></channel></rss>